{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-9809858","patent":{"patent_number":"US-9809858","title":"O-glycan pathway ovarian cancer signature","assignee":null,"inventors":[],"filing_date":"2013-04-05T00:00:00.000Z","publication_date":"2017-11-07T00:00:00.000Z","cpc_codes":["C12Q","G01N","C12Q","C12Q","C12Q","G01N"],"num_claims":9,"abstract":"Biomarkers, methods, assays, and kits are provided for determining the prognosis of and treating a patient with ovarian cancer. Also disclosed are biomarkers, methods, assays, and kits for predicting the sensitivity of ovarian cancer cells to chemotherapy."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"O-glycan pathway ovarian cancer signature","description":"Biomarkers, methods, assays, and kits are provided for determining the prognosis of and treating a patient with ovarian cancer. Also disclosed are biomarkers, methods, assays, and kits for predicting ","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-9809858","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-9809858","citation_suggestion":"Patentable. \"O-glycan pathway ovarian cancer signature\" (US-9809858). https://patentable.app/patents/US-9809858","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-9809858","json":"https://patentable.app/api/llm-context/US-9809858","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-06-06T04:15:29.796Z"}